Chemical Structure : OKI-1546
货号: PC-28533Not For Human Use, Lab Use Only.
OKI-1546 is a potent, selective, covalent and orally bioavailable CDK12/13 inhibitor with IC50 of 15 nM (CDK12), shows 649-, 81-, 11-, and 64-fold selective over CDKs 1, 2, 7, and 9, respectively.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
OKI-1546 is a potent, selective, covalent and orally bioavailable CDK12/13 inhibitor with IC50 of 15 nM (CDK12), shows 649-, 81-, 11-, and 64-fold selective over CDKs 1, 2, 7, and 9, respectively.
OKI-1546 potently inhibits proliferation of multiple cancer cell lines, with IC50 values that correlated with 50% inhibition of CTD pSer2.
OKI-1546 exhibits tumor growth inhibition in the BRCA1-mutant MDA-MB-436 tumor model in mice.
OKI-1546 induces a BRCAness phenotype and synergizes with merestinib in neuroblastoma (NB) cells and in vivo.
| 分子量 | 431.42 | |
| 分子式 | C21H20F3N5O2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Goulding JR, et al. Cell Rep. 2026 Oct 12;45(10):117997.
2. Alexander A. Strait, et al. Cancer Res (2023) 83 (7_Supplement): 1635.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright